Cancer Therapy News and Research

RSS

Sorrento, NantBioScience form joint venture to develop targeted therapies against cancer

Sorrento Therapeutics, Inc. and NantBioScience, Inc., a majority owned subsidiary of NantWorks, LLC, announced today that they have established a joint venture to focus on the development of 'first-in-class' small molecules against targets that have eluded the pharmaceutical industry to date and which may address important drivers of cancer growth including cancer stem cells.

9 Jul 2015

Graphene coating can help boost chemotherapy treatment

Silver is often used as a coating on medical equipment used for chemotherapy. The problem is that this silver coating can break down drugs. Now, researchers have found a graphene coating that will help boost chemotherapy's effects.

9 Jul 2015

Computer model shows how cancerous tumors manipulate blood-vessel growth for their own benefit

Rice University researchers have built a simulation to show how cancerous tumors manipulate blood-vessel growth for their own benefit.

9 Jul 2015

ACCC launches new initiative to facilitate adoption of immuno-oncology in community cancer setting

The Association of Community Cancer Centers today launches the Institute for Clinical Immuno-Oncology, the first of its kind initiative aimed to rapidly facilitate the adoption of immuno-oncology in the community cancer setting.

8 Jul 2015

Researchers develop novel technique to generate activated T cells to tackle advanced melanoma

T cells from patients with melanoma can trigger a protective immune response against the disease according to a new study out of University Hospitals Case Medical Center Seidman Cancer Center and Case Western Reserve University School of Medicine.

8 Jul 2015

UC researcher awarded NCI grant to study effect of MED1 protein on HER2-positive breast cancer

Xiaoting Zhang, PhD, associate professor in the Department of Cancer Biology at the University of Cincinnati College of Medicine, has received a $1.8 million, five-year, R01 award (R01CA197865) from the National Cancer Institute to continue breast cancer research focusing on the function of the protein MED1 on HER2-positive breast cancer.

8 Jul 2015

15-20% women overdiagnosed in Norway's Breast Cancer Screening Programme

For every life saved by Norway's Breast Cancer Screening Programme, five women are over-diagnosed, and have to go through an operation to remove a tumour that otherwise never would have caused problems.

7 Jul 2015

City of Hope researchers to use patients' own modified T cells to treat advanced brain tumors

Already pioneers in the use of immunotherapy, City of Hope researchers are now testing the bold approach to cancer treatment against one of medicine's biggest challenges: brain cancer. This month, they will launch a clinical trial using patients' own modified T cells to fight advanced brain tumors.

7 Jul 2015

INTEGRA announces $10,000 contribution to Dana-Farber Cancer Institute

Following the launch of its limited edition PIPETGIRL pink pipette controller in support of breast cancer research earlier this year - INTEGRA is pleased to announce it has made a $10,000 contribution to the Susan F Smith Center for Womens Cancers at the Dana-Farber Cancer Institute in Boston (MA, USA).

From INTEGRA Biosciences 6 Jul 2015

Scientists to discuss the possibility of predicting evolution at scientific conference in Portugal

Is it possible to predict the evolution of the influenza virus? Or how rapidly bacteria evolve resistance to antibiotics? Or even how cancer cells spread inside a human being? These are some of the main topics of discussion that bring together renowned scientists from all over the world at the scientific conference "Forecasting evolution?" held at the Calouste Gulbenkian Foundation (FCG; Portugal) from 8th to 11th July.

3 Jul 2015

New study finds that cancer survivors who smoke have more barriers to quitting

Cancer survivors who smoke report fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who had quit before or after their diagnosis, according to a new study appearing in Psycho-Oncology.

3 Jul 2015

Low BMI linked to poorer survival in advanced colorectal cancer

Although being overweight with a high body-mass index (BMI) has long been associated with a higher risk for colorectal cancer, thinner patients might not fare as well after treatment for advanced cancer, according to a new study from Duke Medicine.

2 Jul 2015

Danish scientists discover what controls ADAM17 enzyme that aids growth of cancer tumours

Researchers from the University of Copenhagen have discovered what regulates an enzyme that is central to the growth of cancer tumours. This could be of great value to future cancer treatment.

30 Jun 2015

Worldwide Business with kathy ireland conducts exclusive interview with International Cancer Center

MMP (USA) announces Worldwide Business with kathy ireland exclusive interview with International Cancer Center. Dr. Eduardo Lovo, Executive Director & Chief of the Brain Radiosurgery Unit of ICC, explains, "We make the treatment of many types of cancer affordable and accessible to many patients who have no other recourse for treatment. By using the most effective and efficient technologies and equipment, we're breaking new ground in making advanced cancer treatment affordable."

27 Jun 2015

CTCA at Western begins Phase Ib/II trial of new immunotherapy treatment for cancer patients

Cancer Treatment Centers of America at Western Regional Medical Center in Goodyear, Arizona, has begun a new Phase Ib/II clinical trial using a new immunotherapy treatment for patients with advanced kidney, non-small cell lung cancer, pancreatic cancer and colorectal carcinoma.

27 Jun 2015

Discovery sheds light on how the Hippo pathway maintains cellular balance

Researchers at University of California, San Diego School of Medicine have discovered a self-regulating loop in the Hippo pathway, a signaling channel garnering increased attention from cancer researchers due to its role in controlling organ size, cell proliferation and cell death.

27 Jun 2015

UAlberta partnership could transform cancer treatment, improve patient outcomes

A multimillion dollar research partnership announced today at the University of Alberta is giving a "dream team" of researchers the opportunity to potentially transform cancer treatment and better patient outcomes.

25 Jun 2015

Biontech, Siemens enter into strategic collaboration on manufacture of personalized cancer vaccines

Siemens and BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, have entered into a strategic collaboration.

25 Jun 2015

Pan Am Cancer Treatment Center announces publication of immuno-oncology text book

The Pan Am Cancer Treatment Center is pleased to announce the publication of a specialized textbook titled "Immuno-Oncology, from Bench to Bedside" which provides scientific rationale for the use of immunotherapy in the treatment of cancer.

25 Jun 2015

Breast cancer treatment market estimated to increase to over $13.1 billion by 2020

Analysis from business intelligence provider GBI Research - Breast Cancer Therapeutics in Major Developed Markets to 2020 - forecasts the breast cancer treatment market to increase in value from $9.2 billion in 2013 to more than $13.1 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 5.1%.

24 Jun 2015

Cancer Therapy News and Research

Sorrento, NantBioScience form joint venture to develop targeted therapies against cancer

Graphene coating can help boost chemotherapy treatment

Computer model shows how cancerous tumors manipulate blood-vessel growth for their own benefit

ACCC launches new initiative to facilitate adoption of immuno-oncology in community cancer setting

Researchers develop novel technique to generate activated T cells to tackle advanced melanoma

UC researcher awarded NCI grant to study effect of MED1 protein on HER2-positive breast cancer

15-20% women overdiagnosed in Norway's Breast Cancer Screening Programme

City of Hope researchers to use patients' own modified T cells to treat advanced brain tumors

INTEGRA announces $10,000 contribution to Dana-Farber Cancer Institute

Scientists to discuss the possibility of predicting evolution at scientific conference in Portugal

New study finds that cancer survivors who smoke have more barriers to quitting

Low BMI linked to poorer survival in advanced colorectal cancer

Danish scientists discover what controls ADAM17 enzyme that aids growth of cancer tumours

Worldwide Business with kathy ireland conducts exclusive interview with International Cancer Center

CTCA at Western begins Phase Ib/II trial of new immunotherapy treatment for cancer patients

Discovery sheds light on how the Hippo pathway maintains cellular balance

UAlberta partnership could transform cancer treatment, improve patient outcomes

Biontech, Siemens enter into strategic collaboration on manufacture of personalized cancer vaccines

Pan Am Cancer Treatment Center announces publication of immuno-oncology text book

Breast cancer treatment market estimated to increase to over $13.1 billion by 2020

Your guide to microplate readers for cancer research eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News